Sangamo Therapeutics to Present at the Jefferies Cell & Genetic Medicine Summit
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today announced that it will participate in the Jefferies Cell & Genetic Medicine Summit, to be held from September 26-27, 2023 in New York City.
Sandy Macrae, Sangamo's President and Chief Executive Officer is scheduled to present on Wednesday, September 27th at 11:00AM ET. A live webcast of the presentation will be available here and on the Company's Investor Events webpage. A replay of the presentation will be available on the Sangamo Therapeutics website for 90 days after the event.
About Sangamo Therapeutics
Sangamo Therapeutics is a clinical-stage biopharmaceutical company with a robust genomic medicines pipeline. Using ground-breaking science, including our proprietary zinc finger genome engineering technology and manufacturing expertise, Sangamo aims to create new genomic medicines for patients suffering from diseases for which existing treatment options are inadequate or currently don't exist. To learn more, visit www.sangamo.com and connect with us on LinkedIn and Twitter.
A VIP Party and Ribbon-Cutting Ceremony was held for Green Oaks of Valparaiso, a new affordable assisted lifestyle community for older adults is now...
The Galien Foundation, the premier global institution dedicated to honouring innovators in life sciences, today announced the 2024 Prix Galien UK Award candidates for "Best Biotechnology Product," "Best Digital Health Solution," "Best Medical...
Globally, cardiovascular diseases due to atherosclerosis ? the build-up of plaque in arteries ? are the leading cause of death. A new Danish-Spanish research collaboration aims to develop methods to detect atherosclerosis at earlier ages and...
Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, has received confirmation of an extension of its contract with The Norwegian Hospital Procurement Trust (Sykehusinnkjøp HF)...
One in four people with pre-existing medical conditions (25%) say they will not declare all of their medical conditions when buying travel insurance, with 40% of these only declaring what they are currently being treated for.
Of those that would not...
Viewpoint, the esteemed educational program hosted by renowned actor Dennis Quaid, is proud to announce a collaboration with Cedar Community in West Bend, Wisconsin for an upcoming episode that will shed light on the evolving journey of aging. Set to...
